Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Mallinckrodt
AstraZeneca
Colorcon
Medtronic
Merck

Last Updated: November 12, 2019

DrugPatentWatch Database Preview

Larken Labs Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for LARKEN LABS, and what generic and branded alternatives to LARKEN LABS drugs are available?

LARKEN LABS has five approved drugs.



Summary for Larken Labs
US Patents:0
Tradenames:6
Ingredients:5
NDAs:5

Drugs and US Patents for Larken Labs

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Larken Labs OFLOXACIN ofloxacin TABLET;ORAL 076093-002 Sep 2, 2003 DISCN No No   Start Trial   Start Trial
Larken Labs Inc BUTALBITAL AND ACETAMINOPHEN acetaminophen; butalbital TABLET;ORAL 203484-002 Dec 4, 2015 AA RX No No   Start Trial   Start Trial
Larken Labs Inc ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE acetaminophen; caffeine; dihydrocodeine bitartrate TABLET;ORAL 204209-001 Sep 30, 2016 RX No No   Start Trial   Start Trial
Larken Labs OFLOXACIN ofloxacin TABLET;ORAL 076093-001 Sep 2, 2003 DISCN No No   Start Trial   Start Trial
Larken Labs Inc ALLZITAL acetaminophen; butalbital TABLET;ORAL 203484-001 Dec 4, 2015 RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKinsey
Moodys
Merck
Express Scripts
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.